William Blair downgraded Agilon Health (AGL) to Market Perform from Outperform. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on AGL: Agilon Health Reports Revenue Rise Despite Net Loss Agilon Health reports Q3 EPS (29c), consensus (11c) Agilon Health cuts FY24 adjusted EBITDA to (155M)-(135M) from (60M)-(15) Agilon Health downgraded to Sell from Neutral at Citi Agilon Health price target lowered to $4 from $7 at Evercore ISI